HBRM Herborium Group Inc (PK)

Herborium Group, Inc. (OTCBB:HBRM), a developer and marketer of novel botanical therapeutics�, announced today that on April 12, 2007, an interview CEOCFO.biz conducted with Dr. Agnes Olszewski, Herborium�s CEO, was released online by this powerful, bi-weekly Internet publication (http://ceocfointerviews.com/interviews/HBRM-Herborium.htm). CEOCFO.biz has over 100,000 individual and corporate readers each month�representing business and investment communities worldwide, and features interviews with companies publicly traded on US and Canadian stock exchanges, and venture capitalists. The focal point of the story is the rapidly growing market for botanically based medicinal products and Herborium�s business strategy as a leading industry innovator. This new, potentially $500B market is supported by recent changes in the FDA�s regulatory approach (FDA 2004 Guidance For Industry Botanic Drugs Products), the erosion of consumer trust with ethical pharmaceuticals such as Vioxx and HRT due to recent safety problems, and the economics of botanical therapeutics, and botanical drugs which can be developed more quickly and economically than traditional pharmaceuticals. �Herborium is one of the few players in this emerging niche. With our unique botanical therapeutic product candidates, innovative business model and science and marketing partners in the US, Asia and Europe, we expect to more than just make a mark on this emerging sector � we expect to own part of it,� said Dr. Olszewski. This release and oral statements made from time to time by the Company's representatives concerning the same subject matter may contain "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by the Company with the SEC, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements.